Jelle M. Beernink - Publications

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

Journal: European heart journal

Published: July 24, 2026

Feasibility of Decentralised Response-Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease.

Journal: Diabetes, obesity & metabolism

Published: April 30, 2026

Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.

Journal: Diabetes care

Published: April 14, 2026

Association of UACR and UPCR with kidney failure: a pooled analysis of clinical trials.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: February 03, 2026

Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: December 22, 2025

Distinct proteomic signatures of urinary extracellular vesicles link to albuminuria and treatment responses in diabetic kidney disease.

Journal: Kidney international

Published: November 27, 2025

Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes: A Crossover Trial.

Journal: JAMA network open

Published: March 24, 2025

Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial.

Journal: Diabetes, obesity & metabolism

Published: February 07, 2025

Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease-A practical update for clinicians.

Journal: Diabetes, obesity & metabolism

Published: February 04, 2025

Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study.

Journal: Diabetes care

Published: August 03, 2022

Adherence to Statin Therapy and Attainment of LDL Cholesterol Targets in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT).

Journal: Frontiers in pharmacology

Published: March 02, 2022

Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT).

Journal: Diabetes care

Published: October 14, 2020